


Register for your free account today at. Data Link's cloud-based technology platform allows you to search, discover and access data and analytics for seamless integration via cloud APIs.

You can use the bid-ask spread to determine whether to place a market order or limit order when trading, helping you to optimize your price and have a successful order execution. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. The bid-ask spread can indicate a stock’s liquidity, which is how easy it is to buy and sell in the marketplace. The data displayed in the quote bar updates every 3 seconds allowing you to monitor prices in real-time. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. The numbers next to the bid/ask are the “ size”. amount that a seller is currently willing to sell. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest Amarin Announces New REDUCE-IT® Data at ACC.The bid & ask refers to the price that an investor is willing to buy or sell a stock.Amarin Highlights New Evidence of Therapeutic Value of EPA in Reducing Cardiovascular Events in At-Risk Patients Presented at ACC.23/WCC.Statement of Changes in Beneficial Ownership (4).Initial Statement of Beneficial Ownership (3).(OTCQB: NGTF) now in Sonesta International Hotels Multiple Brands Reconstituted Amarin Board Ready for the Challenge of Unlocking True Potential of VASCEPA®/VAZKEPA® (Icosapent Ethyl).Amarin Announces VAZKEPA® (Icosapent Ethyl) Approved by Israel's Ministry of Health.Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O’Connor to Company’s Board of Directors.Amarin to Report First Quarter 2023 Financial Results and Host Conference Call on.
#Amarin stock conversation update
Amarin Reports First Quarter 2023 Financial Results and Provides Business Update.Amarin Highlights New Data Providing Potential Mechanistic Insight into Vascepa®/Vazkepa® (Icosapent Ethyl) Reduction of Cardiovascular Events.

